E25Bio is a biotech company that has developed a rapid, at-home fever panel that detects deadly mosquito-borne illnesses in minutes, not days.
E25Bio enabless earlier diagnosis, with greater accuracy, at lower levels of the healthcare system.
E25Bio was founded in 2018 by Irene Bosch, Bobby Brooke Herrera, and Lee Gehrk. The company is headquartered in Cambridge, Massachusetts.
E25Bio's goal is to be able to distribute more rapid, accurate and affordable detectors for coronavirus that can be distributed at scale across geographies.
E25Bio’s rapid diagnostic tests use nanoparticle technology to capture virus or viral proteins secreted into the human body. The company is transforming the system through development of more rapid, accurate, and affordable detectors for the novel coronavirus that can be distributed at scale across geographies.
E25Bio is backed by Khosla Ventures, The Engine and others. The company raised $2M in a new round on Mar 18, 2020. This brings E25Bio's total funding to $4.3M to date.